| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.10B | 1.07B | 1.11B | 1.22B | 1.18B |
| Gross Profit | 335.95M | 321.59M | 355.19M | 373.27M | 310.46M |
| EBITDA | 207.15M | 244.53M | 254.03M | 248.84M | 216.89M |
| Net Income | 166.75M | 170.37M | 175.42M | 172.55M | 158.32M |
Balance Sheet | |||||
| Total Assets | 1.13B | 1.06B | 940.41M | 822.85M | 791.49M |
| Cash, Cash Equivalents and Short-Term Investments | 661.80M | 604.49M | 548.77M | 394.15M | 281.68M |
| Total Debt | 30.52M | 29.51M | 16.67M | 9.00M | 37.17M |
| Total Liabilities | 188.89M | 226.78M | 214.73M | 180.06M | 238.86M |
| Stockholders Equity | 934.72M | 829.68M | 725.68M | 613.86M | 524.68M |
Cash Flow | |||||
| Free Cash Flow | 147.35M | 127.73M | 265.36M | 227.47M | 81.67M |
| Operating Cash Flow | 180.59M | 150.53M | 273.24M | 236.51M | 89.70M |
| Investing Cash Flow | -272.22M | -6.38M | 36.84M | -55.18M | -65.77M |
| Financing Cash Flow | -90.87M | -79.75M | -119.26M | -112.65M | -12.11M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | HK$825.00M | 4.72 | 19.30% | 8.89% | 2.88% | -2.13% | |
73 Outperform | HK$16.86B | 10.93 | 14.30% | 5.87% | 6.88% | 11.98% | |
72 Outperform | HK$910.27M | 5.23 | 5.84% | 6.04% | -1.81% | -2.23% | |
71 Outperform | HK$67.95B | 14.19 | 15.53% | 4.31% | 8.19% | -6.72% | |
67 Neutral | HK$2.20B | 4.54 | 8.52% | 4.00% | 3.40% | 151.24% | |
63 Neutral | HK$2.19B | 1.51 | 15.14% | 12.14% | -0.95% | 2.58% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |